Colorectal Cancers: An Update on Their Molecular Pathology and Therapy
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 20 October 2024 | Viewed by 1298
Special Issue Editor
Interests: colorectal cancers; thymoma; pulmonary medicine; malignant pleural effusion; video-assisted thoracic surgery; mesothelioma; transthoracic biopsy: bronchoscopy; cancer malnutrition; dietary intervention; cachexia; parenteral nutrition
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Colorectal cancer (CRC) is the 3rd most common cancer in Poland. Its incidence is still increasing. The development of colorectal cancer usually takes several years. There are many risk factors for CRC, which could be eliminated by changing one’s lifestyle. Early symptoms are rectal bleeding, change in bowel habits, and abdominal pain. Faecal occult blood tests and colonoscopy once every 10 years reduces the incidence and mortality of CRC. Modern surgical techniques and new oncological drugs improve the quality of life and increase the survival rate. Proper preoperative arrangements reduce the risk of complications and improve surgical results. Patients with CRC are often at increased risk of anxiety and depression.
This Special Issue is open for submissions from any interested individuals. It is expected that contributions will include original research papers, authoritative and up-to-date reviews, and commentaries on the following topics and areas:
- Novel drugs and surgical techniques for therapy of colorectal disease.
- Molecular mechanisms for anti-colorectal cancer or cancer-preventive effects.
- In vitro, in vivo, and clinical studies related to colorectal cancer.
- Usage of surgical methods in conjunction with cancer chemotherapeutic drugs.
- Challenges and innovative approaches for anti-colorectal cancer drug development.
- Novel strategies for colorectal cancer prevention and intervention.
- Production of anti-colorectal cancer agents using biotechnology.
- Pharmacokinetics and pharmacogenomic studies on anti-colorectal cancer drugs.
Dr. Mariusz Chabowski
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
